Clinical Trials
4 trialsNCT02740712 2023-06-09
DDI
pharmaand GmbH
Phase 1 Completed
NCT01596647 2020-12-21
Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors
Novartis
Phase 1 Completed
NCT01517399 2019-02-12
Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects
Daiichi Sankyo
Phase 1 Completed
NCT00879775 2011-03-29
Efficacy of Caffeine Injection as an Adjuvant to Opioid Therapy in Cancer Pain
Korea Research Foundation
Phase 2 Completed